In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.

A boxed warning for testosterone on major adverse cardiovascular events is out and a new blood pressure warning is in, the ...

For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual sodium ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

Medtronic VP Jason Fontana offered advice for other device developers who might one day be looking for their own NCA.

Strong results to date of Vafseo U.S. launch; expect Vafseo Q1 2025 net product revenues of approximately $10-$11 millionCash resources and cash ...

HealthDay News — Contemporary estrogen-progestin contraceptives are associated with an increased risk for ischemic stroke and myocardial infarction, according to a study published online Feb. 12 in ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...